Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20050268922 A1
Publication typeApplication
Application numberUS 11/196,811
Publication dateDec 8, 2005
Filing dateAug 3, 2005
Priority dateSep 17, 1999
Also published asUS6250307, US6401717, US6523543, US6601585, US6626181, US7063089, US7255109, US20010025642, US20010044587, US20040020498, US20050028830
Publication number11196811, 196811, US 2005/0268922 A1, US 2005/268922 A1, US 20050268922 A1, US 20050268922A1, US 2005268922 A1, US 2005268922A1, US-A1-20050268922, US-A1-2005268922, US2005/0268922A1, US2005/268922A1, US20050268922 A1, US20050268922A1, US2005268922 A1, US2005268922A1
InventorsTimothy Conrad, Mark Knudson, Jerry Griffin
Original AssigneeRestore Medical, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Injectable snoring implant
US 20050268922 A1
Abstract
A method and apparatus for treating snoring of a patient includes providing an implant for altering a dynamic response of a soft palate of the patient to airflow past the soft palate. The implant is embedded in the soft palate to alter the dynamic response. For example, the implant has a mass, stiffness or dampening sufficient to alter the dynamic response following the implantation without substantially impairing a function of the soft palate to close a nasal passage of the patient during swallowing.
Images(9)
Previous page
Next page
Claims(4)
1-13. (canceled)
14. An apparatus to brace or fixate tissue in targeted pharyngeal structures and/or individual anatomic components within the pharyngeal conduit comprising a material including one or more liquid components that is injected into tissue as a liquid or slurry and that sets in situ to create a non-liquid mechanical implant structure.
15. A system comprising at least two apparatuses, at least one of the apparatuses comprising an apparatus as defined in claim 14.
15. A method for implanting an apparatus in targeted pharyngeal structures and/or individual anatomic components within the pharyngeal conduit comprising the steps of providing at least one apparatus as defined in claim 14, and injecting the apparatus in targeted pharyngeal structures and/or individual anatomic components within the pharyngeal conduit.
Description
  • [0001]
    This application is a continuation of U.S. patent application Ser. No. 10/629,490 filed Jul. 29, 2003; which is a continuation of U.S. patent application Ser. No. 09/872,545 filed Jun. 1, 2001, now U.S. Pat. No. 6,626,181; which is a continuation of U.S. patent application Ser. No. 09/398,991 filed Sep. 17, 1999, now U.S. Pat. No. 6,250,307; which applications are incorporated herein by reference.
  • BACKGROUND
  • [0002]
    1. Field of the Invention
  • [0003]
    This invention is directed to methods and apparatuses for treating snoring.
  • [0004]
    2. Description of the Prior Art
  • [0005]
    Snoring has received increased scientific and academic attention. One publication estimates that up to 20% of the adult population snores habitually. Huang, et al., “Biomechanics of Snoring”, Endeavour, p. 96-100, Vol. 19, No. 3 (1995). Snoring can be a serious cause of marital discord. In addition, snoring can present a serious health risk to the snorer. In 10% of habitual snorers, collapse of the airway during sleep can lead to obstructive sleep apnea syndrome. Id.
  • [0006]
    Notwithstanding numerous efforts to address snoring, effective treatment of snoring has been elusive. Such treatment may include mouth guards or other appliances worn by the snorer during sleep. However, patients find such appliances uncomfortable and frequently discontinue use (presumably adding to marital stress).
  • [0007]
    Electrical stimulation of the soft palate has been suggested to treat snoring and obstructive sleep apnea. See, e.g., Schwartz, et al., “Effects of electrical stimulation to the soft palate on snoring and obstructive sleep apnea”, J. Prosthetic Dentistry, pp. 273-281 (1996). Devices to apply such stimulation are described in U.S. Pat. Nos. 5,284,161 and 5,792,067. Such devices are appliances requiring patient adherence to a regimen of use as well as subjecting the patient to discomfort during sleep. Electrical stimulation to treat sleep apnea is discussed in Wiltfang, et al., “First results on daytime submandibular electrostimulation of suprahyoidal muscles to prevent night-time hypopharyngeal collapse in obstructive sleep apnea syndrome”, International Journal of Oral & Maxillofacial Surgery, pp. 21-25 (1999).
  • [0008]
    Surgical treatments have been employed. One such treatment is uvulopalatopharyngoplasty. In this procedure, so-called laser ablation is used to remove about 2 cm of the trailing edge of the soft palate thereby reducing the soft palate's ability to flutter between the tongue and the pharyngeal wall of the throat. The procedure is frequently effective to abate snoring but is painful and frequently results in undesirable side effects. Namely, removal of the soft palate trailing edge comprises the soft palate's ability to seal off nasal passages during swallowing and speech. In an estimated 25% of uvulopalatopharyngoplasty patients, fluid escapes from the mouth into the nose while drinking. Huang, et al., supra at 99. Uvulopalatopharyngoplasty (UPPP) is also described in Harries, et al., “The Surgical treatment of snoring”, Journal of Laryngology and Otology, pp. 1105-1106 (1996) which describes removal of up to 1.5 cm of the soft palate. Assessment of snoring treatment is discussed in Cole, et al., “Snoring: A review and a Reassessment”, Journal of Otolaryngoloy, pp. 303-306 (1995).
  • [0009]
    Huang, et al., supra, describe the soft palate and palatal snoring as an oscillating system which responds to airflow over the soft palate. Resulting flutter of the soft palate (rapidly opening and closing air passages) is a dynamic response generating sounds associated with snoring. Huang, et al., propose an alternative to uvulopalatopharyngoplasty. The proposal includes using a surgical laser to create scar tissue on the surface of the soft palate. The scar is to reduce flexibility of the soft palate to reduce palatal flutter. Huang, et al., report initial results of complete or near-complete reduction in snoring and reduced side effects.
  • [0010]
    Surgical procedures such as uvulopalatopharyngoplasty and those proposed by Huang, et al., continue to have problems. The area of surgical treatment (i.e., removal of palatal tissue or scarring of palatal tissue) may be more than is necessary to treat the patient's condition. Surgical lasers are expensive. The proposed procedures are painful with drawn out and uncomfortable healing periods. The procedures have complications and side effects and variable efficacy (e.g., Huang, et al., report promising results in 75% of patients suggesting a full quarter of patients are not effectively treated after painful surgery). The procedures may involve lasting discomfort. For example, scar tissue on the soft palate may present a continuing irritant to the patient. Importantly, the procedures are not reversible in the event they happen to induce adverse side effects not justified by the benefits of the surgery.
  • SUMMARY OF THE INVENTION
  • [0011]
    According to a preferred embodiment of the present invention, methods and apparatuses are disclosed for treating snoring of a patient. The invention includes providing an implant for altering a dynamic response of a soft palate of the patient to airflow past the soft palate. The implant is embedded in the soft palate to alter the dynamic response. For example, the implant has a mass, stiffness or dampening sufficient to alter the dynamic response following the implantation without substantially impairing a function of the soft palate to close a nasal passage of the patient during swallowing.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0012]
    FIG. 1 is a side sectional view of a portion of a human head showing a soft palate in a relaxed state and in relation in adjacent anatomical features;
  • [0013]
    FIG. 2 is a portion of the view of FIG. 1 showing the soft palate in a flexed state;
  • [0014]
    FIG. 3 is a front view of an interior of the mouth shown in FIG. 1 and showing an area to be ablated according to a first prior art surgical procedure;
  • [0015]
    FIG. 4 is the view of FIG. 3 and showing an area to be scarred according to a second prior art surgical procedure;
  • [0016]
    FIG. 5 is a schematic representation of a spring-mass system model of the soft palate;
  • [0017]
    FIG. 6 is the view of FIG. 1 with the soft palate containing an implant according to a first embodiment of the present invention;
  • [0018]
    FIG. 7 is the view of FIG. 3 showing the embodiment of FIG. 6;
  • [0019]
    FIG. 8 is a cross-sectional view of the implant of FIG. 6;
  • [0020]
    FIG. 9 is a first modification of the implant of FIG. 8 having a tissue in-growth layer;
  • [0021]
    FIG. 10 is a second modification of the implant of FIG. 8 having a smooth outer layer;
  • [0022]
    FIG. 11 is the view of FIG. 6 with the soft palate containing an implant according to a second embodiment of the present invention;
  • [0023]
    FIG. 12 is the view of FIG. 7 showing the embodiment of FIG. 11;
  • [0024]
    FIG. 13 is a perspective view of the implant of FIG. 11;
  • [0025]
    FIG. 14 is a cross-sectional view of the implant of FIG. 13;
  • [0026]
    FIG. 15 is a view of the implant of FIG. 14 with the implant pre-formed to assume the shape of a soft palate in a relaxed state;
  • [0027]
    FIG. 16 is the view of FIG. 14 with the implant constructed to have greater flexion in a downward direction;
  • [0028]
    FIG. 17 is an exploded perspective view of first modification of the implant of FIG. 13;
  • [0029]
    FIG. 18 is a perspective view of a modification of a housing of the embodiment of FIG. 17;
  • [0030]
    FIG. 19 is a side section view of a second modification of the implant of FIG. 13;
  • [0031]
    FIG. 20 is a cross-sectional view of an implant that is another embodiment of the present invention, the implant is shown in a flattened orientation;
  • [0032]
    FIG. 21 is a cross-sectional view of the implant of FIG. 20 in an expanded orientation;
  • [0033]
    FIG. 22 shows the implant of FIG. 20 in the flattened orientation and implanted in the soft palate; and
  • [0034]
    FIG. 23 shows the implant in FIG. 21 in the expanded orientation and implanted in the soft palate.
  • DESCRIPTION OF THE PREFERRED EMBODIMENT
  • [0035]
    For ease of understanding the present invention, the dynamics of snoring are explained with reference to FIGS. 1-4. The hard palate HP overlies the tongue T and forms the roof of the mouth M. The hard palate HP includes a bone support B and does not materially deform during breathing. The soft palate SP is soft and is made up of mucous membrane, fibrous and muscle tissue extending rearward from the hard palate HP. A leading end LE of the soft palate SP is anchored to the trailing end of the hard palate HP. A trailing end TE of the soft palate SP is unattached. Since the soft palate SP is not structurally supported by bone or hard cartilage, the soft palate SP droops down from the plane of the hard palate HP in an arcuate geometry of repose.
  • [0036]
    The pharyngeal airway passes air from the mouth M and the nasal passages N into the trachea TR. The portion of the pharyngeal airway defined between opposing surfaces of the upper surface of the soft palate SP and the wall of the throat is the nasopharynx NP.
  • [0037]
    During normal breathing, the soft palate SP is in the relaxed state shown in FIG. 1 with the nasopharynx NP unobstructed and with air free to flow into the trachea TR from both the mouth M and the nostrils N.
  • [0038]
    During swallowing, the soft palate SP flexes and extends (as shown in FIG. 2) to close the nasopharynx NP thereby preventing fluid flow from the mouth M to the nasal passages N. Simultaneously, the epiglottis EP closes the trachea TR so that food and drink pass only into the esophagus ES and not the trachea TR. The soft palate SP is a valve to prevent regurgitation of food into the nose N. The soft palate SP also regulates airflow through the nose N while talking. Since the soft palate SP performs such important functions, prior art techniques for surgically altering the soft palate SP can compromise these functions.
  • [0039]
    The majority of snoring is caused by the soft palate SP flapping back and forth. If breathing is solely through the nose N with the mouth closed, the trailing edge TE of the soft palate SP is sucked into the nasopharyngeal space NP obstructing the airway and subsequently falls opening the airway in a repeating cycle. When the mouth is open, air flows over the upper and lower surfaces of the soft palate SP causing the soft palate SP to flap up and down alternating in obstructing the oral and nasal passageways M, N. The snoring sound is generated by impulses caused by rapid obstruction and opening of airways. Huang, et al., state the airway passage opening and closing occurs 50 times per second during a snore. Huang, et al., utilize a spring-mass model (FIG. 5) to illustrate oscillation of the soft palate in response to airflow (where the soft palate is the ball B of mass depending by a spring S from a fixed anchor A).
  • [0040]
    Huang, et al., analogize the shortening of the soft palate SP in uvulopalatopharyngoplasty as effectively raising the critical air flow speed at which soft palate flutter will occur. The shaded area SA in FIG. 3 shows the area of the trailing end TE of the soft palate SP to be removed during this procedure. The alternative procedure proposed by Huang, et al., reduces the flexibility of the soft palate SP through surface scarring which is asserted as effecting the critical flow speed. The shaded area SA′ in FIG. 4 shows the area to be scarred by this alternate procedure. In FIG. 4, dashed line L shows the demarcation between the soft and hard palates.
  • [0041]
    Using the spring-mass model of FIG. 5 as a convenient model of the soft palate SP, the present invention is directed to a surgical implant into the soft palate SP to alter the elements of the model and thereby alter the dynamic response of the soft palate SP to airflow. The implant can alter the mass of the model (the ball B of FIG. 5), the spring constant of the spring S, the dampening of the spring S or any combination of these elements. Unlike the prior art surgical techniques, the implants that will be described are easy to insert in a small incision resulting in reduced patient discomfort and are not exposed to the interior of the mouth (such as the surface scarring of Huang, et al.) as a patient irritant. Also, as will be described, the degree of dynamic remodeling can be fine tuned avoiding the need for excessive anatomical modification and are reversible in the event of adverse consequences.
  • [0042]
    FIGS. 6-7 illustrate a first embodiment of the present invention where individual units 10 of mass (in the form of implantable modular devices such as spheres or implants of other geometry) are imbedded in the soft palate SP in close proximity to the trailing end TE. With reference to the model of FIG. 5, the spheres add mass to the mass-spring system thereby altering dynamic response to airflow and adding resistance to displacement and accelerating. The placement of the units 10 of mass also alter the location of the soft palate's center of mass further altering the model and dynamic response.
  • [0043]
    The embodiment of FIGS. 6-10 is tunable to a particular patient in that multiple modules 10 can be implanted (as illustrated in FIG. 7). This permits the surgeon to progressively increase the number of implanted modules 10 until the altered dynamic response is such that snoring inducing oscillation is abated at normal airflow. The individual modules 10 may be placed into the soft palate SP through small individual incisions closed by sutures which is much less traumatic than the gross anatomical destruction of uvulopalatopharyngoplasty or the large surface area scarring proposed by Huang, et al.
  • [0044]
    Preferably, such modules 10 of mass are solid modules such as spheres of biocompatible material which are radiopaque (or radio-marked) and compatible with magnetic resonance imaging (MRI). Titanium is such a material. By way of non-limiting example, the modules 10 of mass may be about 2-4 mm in diameter. In the case of pure, non-sintered titanium, each such sphere 10 would add 0.15-1.22 gm of mass to the trailing end TE of the soft palate SP and contribute to re-modeling the mass distribution of the soft palate SP. An example of an alternative material is any biocompatible ceramic.
  • [0045]
    As shown in FIG. 9, the spheres (labeled 10′ to distinguish from the version 10 of FIG. 8) may be sintered throughout or otherwise provided with tissue growth inducing material 12 on their outer surface. Such material may be a sintered outer layer or a coating or covering such as a polyester fabric jacket. Such material permits and encourages tissue in-growth to secure the implant 10′ in place. Also, placement of an implant 10 or 10′ will induce a fibrotic response acting to stiffen the soft palate SP (and further alter the dynamic response and resistance to displacement and acceleration). A sintered or coated sphere 10′ will enhance the fibrotic response and resulting stiffening.
  • [0046]
    While tissue in-growth and enhanced fibrotic response have the benefits described above, such embodiments may make the implant 10′ more difficult to remove in the event reversal of the procedure is desired. Therefore, as shown in FIG. 10 as an alternative, the spheres (labeled 10″ to distinguish from the implants 10, 10′) may be coated with smooth coating 14 (such as parylene or PTFE) to reduce fibrosis.
  • [0047]
    The embodiments of FIGS. 6-10 add to and relocate the mass of the spring-mass system of FIG. 5 to remodel the dynamic response. The amount of mass is selected to alter the dynamic response but not preclude the soft palate SP being moved to close off nasal passages N during swallowing. Through fibrotic response and incision healing, the spring S of the model is stiffened.
  • [0048]
    In addition to modifying the mass profile of the spring-mass system, the spring component S of FIG. 5 can be modified (alone or in combination with mass modification) to alter dynamic response. FIG. 11-16 illustrate an implant 20 in the form of a flexible strip for placement in the soft palate. The use of the term “strip” herein is not intended to be limited to long, narrow implants but can also include plates or other geometries implanted to alter the dynamic model of the soft palate SP. Elongated strips are presently anticipated as a preferred geometry to facilitate ease of implant.
  • [0049]
    The strip 20 has a transverse dimension less than a longitudinal dimension. By way of non-limiting example, the strip may have a length LS of about 20-30 mm, a thickness TS of about 2-4 mm and a width WS of 5-10 mm. As shown in FIG. 11, the strip 20 is embedded in the soft palate SP with the longitudinal dimension LS extending from adjacent the hard palate HP toward the trailing end TE of the soft palate SP. As shown in FIG. 12, multiple strips 20 may be embedded in the soft palate SP extending either straight rearward or angled to the sides while extending rearward. The strips 20 may be formed straight (FIG. 14) or pre-shaped (FIG. 15) to have a rest shape approximate to the side-cross section shape of the soft palate in a relaxed state.
  • [0050]
    The strips 20 may be any flexible, biocompatible material and are preferably radiopaque or radio-marked as well as MRI compatible. The strips 20 need not be elastic and having a material spring constant biasing them to their original shape. Such strips 20 could simply be flexible, plastically deformable strips which are stiffer than the soft palate SP to reinforce the soft palate SP and assist the soft palate SP in resisting deflection due to airflow. Such stiffening of the soft palate SP stiffens and dampens the spring S in the spring-mass system of FIG. 5 and alters the dynamic response of the soft palate SP. The strip 20 may be a spring having a spring constant to further resist deflection of the soft palate SP as well as urging the soft palate SP to the relaxed state of FIG. 5. The stiffness of the strip 20, a spring constant of the strip 20, and the number of strips 20, are selected to avoid preclusion of closure of the soft palate SP during swallowing. Examples of suitable materials include titanium and nitinol (a well-known nickel-titanium alloy). As with the examples of FIGS. 9 and 10, the strips 20 may be provided with tissue in-growth surfaces or may be coated as desired. Also, the strips may be structurally modified to control their flexibility. In FIG. 16, the bottom 22 of the strip 20 (facing the tongue after placement) is provided with transverse notches 24 to enhance downward flexion of the strip 20 relative to upward flexion of the strip 20 following placement.
  • [0051]
    FIG. 17 provides an alternative to the strips 20 of FIG. 13. In FIG. 17, the strip 20′ includes a housing 26 having an interior space 28 with an access opening 25. The interior space 28 extends in the longitudinal dimension of the housing 26. The strip 20′ further includes a longitudinal insert 32 sized to be passed through the access opening 25 and into the space 28. By way of non-limiting example, the housing 26 could be silicone rubber (with radio-markers, not shown, to indicate placement) and the inserts 32 could be titanium rods or other flexible member. With the embodiment of FIG. 17, the housing 26 (without an insert) may be embedded in the soft palate SP. The housing 26 acts independently as a stiffening strip to add stiffness to the soft palate SP to alter the soft palate's dynamic response. In the event further stiffening or a spring action is desired, the implant 20′ can be selectively tuned to the patient's unique dynamic model by placing the insert 32 into the space 28 at the time of initial surgery or during a subsequent procedure. The embodiment of FIG. 17, permits selection of an insert 32 from a wide variety of materials and construction so that an insert 32 of desired characteristics (e.g., stiffness and spring action) can be selected to be inserted in the space 28 and alter the dynamic response as desired. The embodiment of FIG. 17 also permits later removal of the insert 32 and replacement with a different insert 32 of different properties for post-surgery modification of the soft palate's dynamic response.
  • [0052]
    The embodiment of FIG. 18 is similar to that of FIG. 17. The housing 26′ is provided with multiple, parallel-aligned interior spaces 28′ and access openings 25′. In addition to the function and benefits of the embodiment of FIG. 17, the number of inserts 32 may be varied to alter and adjust the dynamic response of the soft palate SP.
  • [0053]
    FIG. 19 illustrates a still further embodiment of the strip implant. In FIG. 19, the strip 20′″ is a bladder having a housing 26″ in the form of a completely sealed envelope of flexible synthetic material defining an interior space 28″. The envelope 26″ is preferably self-sealing following needle injection. Fluid is injected into the housing 26″ (e.g., through hypodermic needle 40 injection) to stiffen the strip 20′″. Addition of fluid further stiffens the strip 20′″ and further alters the dynamic response of the soft palate SP. Removal of fluid increases the flexibility. Unlike the embodiments of FIG. 17 (where inserts 32 are most effectively replaced post-operatively through incision to alter flexibility), the embodiment of FIG. 19 permits selectively varying flexibility of the soft palate SP through needle injection. An alternative to FIG. 19 is to fill the space 28″ with a so-called phase change polymer and inject a stiffening agent into the space 28″ to alter the flexibility of the polymer.
  • [0054]
    FIGS. 20-23 illustrate a still further embodiment of the present invention. In the foregoing embodiments, the spring-mass system of FIG. 5 is altered by altering the mass of the soft palate SP or the spring characteristics of the soft palate SP. The dynamic response can also be altered by altering the force acting on the spring-mass system. Namely, the force acting on the soft palate SP is generated by airflow over the surface of the soft palate. The soft palate acts as an airfoil which generates lift in response to such airflow. By modifying the longitudinal (i.e., anterior to posterior) cross-sectional geometry of the soft palate SP, the aerodynamic response and, accordingly, the dynamic response are altered.
  • [0055]
    In the embodiments of FIGS. 20-23, the implant 30 is inserted into the soft palate SP through an incision. The implant 30 has an oval shape to cause deformation of the geometry of the soft palate SP. Prior to implantation, the implant 30 is preferably formed as a flat oval (FIGS. 20 and 22) for ease of insertion. After implantation, the implant 30 expands to an enlarged oval (FIGS. 21 and 23). While such expansion could be accomplished mechanically (i.e., through balloon expansion), the implant 30 is preferably formed as a shape-memory alloy (such as nitinol) which expands to the enlarged shape in response to the warmth of the body. In addition to changing the aerodynamics of the soft palate SP, the implant 30 can be constructed with a mass and stiffness as desired to alter the spring and mass components of the spring-mass system of FIG. 5.
  • [0056]
    The foregoing describes numerous embodiments of an invention for an implant for the soft palate to alter a dynamic response of the soft palate. The invention is much less traumatic than prior surgical treatments. Further, the invention permits use of reversible procedures as well as procedures which can be selectively tuned both during surgery and post-operatively. Having described the invention, alternatives and embodiments may occur to one of skill in the art. For example, the strips of FIG. 13 may be encased coiled springs which may be tightened to further stiffen the strips. Such strips may also be hinged segments. It is intended that such modifications and equivalents shall be included within the scope of the following claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3998209 *Dec 16, 1975Dec 21, 1976Macvaugh Gilbert SSnoring deconditioning system and method
US4830008 *Feb 16, 1988May 16, 1989Meer Jeffrey AMethod and system for treatment of sleep apnea
US4978323 *Aug 10, 1989Dec 18, 1990George FreedmanSystem and method for preventing closure of passageways
US5046512 *Aug 30, 1989Sep 10, 1991Murchie John AMethod and apparatus for treatment of snoring
US5052409 *Oct 31, 1990Oct 1, 1991Tepper Harry WOral appliance for tongue thrust correction
US5133354 *Nov 8, 1990Jul 28, 1992Medtronic, Inc.Method and apparatus for improving muscle tone
US5176618 *Aug 27, 1990Jan 5, 1993George FreedmanSystem for preventing closure of passageways
US5178156 *Jun 12, 1990Jan 12, 1993Chest CorporationApnea preventive stimulating device
US5190053 *Feb 28, 1991Mar 2, 1993Jeffrey A. Meer, Revocable Living TrustMethod and apparatus for electrical sublingual stimulation
US5281219 *Aug 24, 1992Jan 25, 1994Medtronic, Inc.Multiple stimulation electrodes
US5284161 *Nov 12, 1992Feb 8, 1994Karell Manuel LSnopper-the snoring stopper anti-snoring mouth device
US5428022 *Jul 29, 1992Jun 27, 1995Collagen CorporationComposition of low type III content human placental collagen
US5456662 *May 9, 1994Oct 10, 1995Edwards; Stuart D.Method for reducing snoring by RF ablation of the uvula
US5514131 *Sep 23, 1994May 7, 1996Stuart D. EdwardsMethod for the ablation treatment of the uvula
US5523543 *Sep 9, 1994Jun 4, 1996Litel InstrumentsLaser ablation control system and method
US5540733 *Sep 21, 1994Jul 30, 1996Medtronic, Inc.Method and apparatus for detecting and treating obstructive sleep apnea
US5591216 *May 19, 1995Jan 7, 1997Medtronic, Inc.Method for treatment of sleep apnea by electrical stimulation
US5674191 *Aug 18, 1995Oct 7, 1997Somnus Medical Technologies, Inc.Ablation apparatus and system for removal of soft palate tissue
US5718702 *May 6, 1996Feb 17, 1998Somnus Medical Technologies, Inc.Uvula, tonsil, adenoid and sinus tissue treatment device and method
US5792067 *Mar 13, 1996Aug 11, 1998Karell; Manuel L.Apparatus and method for mitigating sleep and other disorders through electromuscular stimulation
US5843021 *Aug 5, 1997Dec 1, 1998Somnus Medical Technologies, Inc.Cell necrosis apparatus
US5897579 *Nov 26, 1997Apr 27, 1999Mount Sinai School Of MedicineMethod of relieving airway obstruction in patients with bilateral vocal impairment
US5922006 *Jul 29, 1997Jul 13, 1999Sugerman; Joseph H.Nasal appliance
US5979456 *Apr 22, 1996Nov 9, 1999Magovern; George J.Apparatus and method for reversibly reshaping a body part
US6098629 *Apr 7, 1999Aug 8, 2000Endonetics, Inc.Submucosal esophageal bulking device
US6106541 *May 5, 1998Aug 22, 2000Hurbis; Charles G.Surgically implantable nasal dilator
US6216702 *May 29, 1997Apr 17, 2001Camtech AsInternal registration of gas/air—and other fluid flows in a human body and use of pressure sensors for such registration
US6250307 *Sep 17, 1999Jun 26, 2001Pi Medical, Inc.Snoring treatment
US6401717 *Nov 5, 1999Jun 11, 2002Pi Medical, Inc.Snoring treatment
US6431174 *Aug 10, 2000Aug 13, 2002Pi Medical, Inc.Method and apparatus to treat conditions of the naso-pharyngeal area
US6450169 *Feb 25, 2000Sep 17, 2002Pi Medical, Inc.Braided implant for snoring treatment
US6453905 *Feb 25, 2000Sep 24, 2002Pi Medical, Inc.Multi-component snoring treatment
US6502574 *Nov 14, 2001Jan 7, 2003Pi Medical, Inc.Lateral stiffening snoring treatment
US6513530 *Mar 21, 2001Feb 4, 2003Pi Medical, Inc.Braided palatal implant for snoring treatment
US6513531 *Mar 21, 2001Feb 4, 2003Pi Medical, Inc.Proximal placement of snoring treatment implant
US6516806 *Mar 21, 2001Feb 11, 2003Pi Medical, Inc.Compliant snoring treatment implant
US6523542 *Mar 21, 2001Feb 25, 2003Pi Medical, Inc.Snoring treatment implant and method
US6546936 *Jul 3, 2002Apr 15, 2003Restore Medical, Inc.Method and apparatus to treat conditions of the naso-pharyngeal area
US6601584 *Mar 21, 2001Aug 5, 2003Pi Medical, Inc.Contracting snoring treatment implant
US6601585 *Jun 1, 2001Aug 5, 2003Restore Medical, Inc.Expandable snoring implant
US6626181 *Jun 1, 2001Sep 30, 2003Restore Medical, Inc.Stiff snoring implant
US6634362 *Jan 3, 2002Oct 21, 2003Restore Medical, Inc.Braided implant for snoring treatment
US6679918 *Feb 13, 1998Jan 20, 2004Centerpulse Biologics Inc.Implantable putty material
US6742524 *Mar 21, 2003Jun 1, 2004Restore Medical, Inc.Method and apparatus to treat conditions of the naso-pharyngeal area
US6748950 *Apr 30, 2001Jun 15, 2004Closure Medical CorporationCompositions and medical procedure to treat snoring
US6848447 *May 7, 2003Feb 1, 2005Restore Medical, Inc.Braided implant for snoring treatment
US20040045556 *Sep 6, 2002Mar 11, 2004Swan MedicalSystems and methods for moving and/or restraining tissue in the upper respiratory system
US20040134491 *Jul 22, 2003Jul 15, 2004Quiescence MedicalApparatus and methods for treating sleep apnea
USRE36120 *Feb 7, 1996Mar 2, 1999Karell; Manuel L.Snopper--the snoring stopper anti-snoring mouth device
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7565191 *Sep 29, 2005Jul 21, 2009Senorx, Inc.Tissue site markers for in vivo imaging
US7954494Jan 12, 2009Jun 7, 2011Connor Robert ADevice with actively-moving members that hold or move the tongue
US7975700Feb 7, 2006Jul 12, 2011Koninklijke Philips Electronics N.V.System for adjustable tissue anchors
US7992567Feb 7, 2006Aug 9, 2011Koninklijke Philips Electronics N.V.System and method for percutaneous glossoplasty
US8096303Aug 8, 2007Jan 17, 2012Koninklijke Philips Electronics N.VAirway implants and methods and devices for insertion and retrieval
US8157862Dec 10, 2010Apr 17, 2012Senorx, Inc.Tissue marking implant
US8177792Nov 18, 2009May 15, 2012Senorx, Inc.Plugged tip delivery tube for marker placement
US8219182Jul 10, 2012Senorx, Inc.Cavity-filling biopsy site markers
US8224424Jul 13, 2009Jul 17, 2012Senorx, Inc.Tissue site markers for in vivo imaging
US8311610Jan 22, 2009Nov 13, 2012C. R. Bard, Inc.Biopsy tissue marker
US8361082Mar 1, 2011Jan 29, 2013Senorx, Inc.Marker delivery device with releasable plug
US8371307Aug 8, 2007Feb 12, 2013Koninklijke Philips Electronics N.V.Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US8401622Dec 17, 2007Mar 19, 2013C. R. Bard, Inc.Biopsy marker with in situ-generated imaging properties
US8437834Sep 28, 2011May 7, 2013C. R. Bard, Inc.Breast marker
US8447386Dec 14, 2010May 21, 2013Senorx, Inc.Marker or filler forming fluid
US8486028Sep 30, 2011Jul 16, 2013Bard Peripheral Vascular, Inc.Tissue marking apparatus having drug-eluting tissue marker
US8498693Apr 8, 2011Jul 30, 2013Senorx, Inc.Intracorporeal marker and marker delivery device
US8579931Sep 29, 2011Nov 12, 2013Bard Peripheral Vascular, Inc.Apparatus for the percutaneous marking of a lesion
US8626269Jun 8, 2011Jan 7, 2014Senorx, Inc.Fibrous marker and intracorporeal delivery thereof
US8626270Jun 13, 2012Jan 7, 2014Senorx, Inc.Cavity-filling biopsy site markers
US8634899Feb 3, 2006Jan 21, 2014Bard Peripheral Vascular, Inc.Multi mode imaging marker
US8639315May 16, 2013Jan 28, 2014Senorx, Inc.Marker or filler forming fluid
US8668737Mar 21, 2012Mar 11, 2014Senorx, Inc.Tissue marking implant
US8670818Dec 30, 2008Mar 11, 2014C. R. Bard, Inc.Marker delivery device for tissue marker placement
US8718745May 25, 2010May 6, 2014Senorx, Inc.Tissue site markers for in vivo imaging
US8757163Jan 16, 2012Jun 24, 2014Koninklijke Philips N.V.Airway implants and methods and devices for insertion and retrieval
US8784433Apr 27, 2012Jul 22, 2014Senorx, Inc.Plugged tip delivery tube for marker placement
US8880154Jul 19, 2013Nov 4, 2014Senorx, Inc.Fibrous marker and intracorporeal delivery thereof
US8965486Dec 6, 2013Feb 24, 2015Senorx, Inc.Cavity filling biopsy site markers
US9039763Jan 28, 2014May 26, 2015Senorx, Inc.Tissue marking implant
US9042965Mar 6, 2013May 26, 2015C. R. Bard, Inc.Biopsy marker with in situ-generated imaging properties
US9044162Jan 25, 2013Jun 2, 2015Senorx, Inc.Marker delivery device with releasable plug
US9149341Nov 21, 2011Oct 6, 2015Senorx, IncDeployment of polysaccharide markers for treating a site within a patient
US9237937Feb 20, 2015Jan 19, 2016Senorx, Inc.Cavity-filling biopsy site markers
US20060036165 *Sep 29, 2005Feb 16, 2006Senorx, Inc.Tissue site markers for in vivo imaging
USD715442Sep 24, 2013Oct 14, 2014C. R. Bard, Inc.Tissue marker for intracorporeal site identification
USD715942Sep 24, 2013Oct 21, 2014C. R. Bard, Inc.Tissue marker for intracorporeal site identification
USD716450Sep 24, 2013Oct 28, 2014C. R. Bard, Inc.Tissue marker for intracorporeal site identification
USD716451Sep 24, 2013Oct 28, 2014C. R. Bard, Inc.Tissue marker for intracorporeal site identification
Classifications
U.S. Classification128/898, 623/23.72
International ClassificationA61B19/00, A61F2/02, A61F5/56
Cooperative ClassificationA61F5/566
European ClassificationA61F5/56B